发明名称 Pre-or post-exposure treatment for filovirus or arenavirus infection
摘要 The compositions and methods of the invention described herein provide pre- or post-exposure treatments against filovirus or arenavirus infection by expressing one or more genes (e.g., two ore more genes) from filoviruses or arenaviruses in a delivery vehicle (e.g., a recombinant viral vector or a liposome).
申请公布号 US8796013(B2) 申请公布日期 2014.08.05
申请号 US200812809348 申请日期 2008.12.17
申请人 Trustees of Boston University;Boston Medical Center Corporation 发明人 Geisbert Thomas W.
分类号 C12N15/00;A61K39/12 主分类号 C12N15/00
代理机构 Clark & Elbing LLP 代理人 Clark & Elbing LLP ;Clark Paul T.;Armstrong Todd
主权项 1. A method of inhibiting or treating infection by Sudan species of Ebola virus (SEBOV) in a subject exposed to said SEBOV, said method comprising administering to said subject no later than 30 minutes after infection by said SEBOV a pharmaceutical composition comprising a recombinant viral vector that encodes at least a glycoprotein from said SEBOV, wherein the glycoprotein is heterologous to the viral vector.
地址 Boston MA US